The IL-7Rα pathway is quantitatively and functionally altered in CD8 T cells in multiple sclerosis

Area of Science:

• Immunology
• Neuroimmunology
• Cell Biology

Background:

• The Interleukin-7 receptor alpha (IL-7Rα) single nucleotide polymorphism rs6897932 is linked to increased multiple sclerosis (MS) risk.
• IL-7Rα plays a role in T cell regulation, but its specific involvement in MS pathogenesis remains unclear.

Purpose of the Study:

• To investigate differences in IL-7Rα expression and function between CD4 and CD8 lymphocyte subsets in MS patients and healthy controls.
• To explore the role of IL-7Rα in the context of MS lesions.

Main Methods:

• Flow cytometry to analyze IL-7Rα expression on CD4 and CD8 T cell subsets.
• In vitro IL-7 stimulation assays to assess STAT5 activation and granzyme expression.
• Immunohistochemistry on postmortem MS brain tissue to examine IL-7Rα and IL-7 expression in lesions.

Main Results:

• MS patients exhibited a higher frequency of IL-7Rα-expressing CD8 effector memory T cells.
• Increased IL-7Rα membrane expression was observed on naive and memory CD8 T cells in MS patients.
• IL-7 stimulation induced stronger STAT5 activation in CD8 effector memory cells and differential granzyme expression in MS patients.
• IL-7 and CD8+IL-7Rα+ cells were found in preactive MS lesions, but not active ones.

Conclusions:

• Elevated IL-7Rα expression and enhanced IL-7 responsiveness in CD8 T cells may contribute to MS pathogenesis.
• IL-7Rα-expressing CD8 T cells are implicated in the early stages of MS lesion development.
• Targeting the IL-7Rα pathway in CD8 T cells could be a potential therapeutic strategy for MS.